Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges

被引:0
|
作者
He, Yan-Fei [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hlth Management Ctr, 6 Fucheng Rd, Beijing 100048, Peoples R China
关键词
Unresectable hepatocellular carcinoma; Conversion therapy; Challenges; Advances; Advanced hepatocellular carcinoma; Targeted therapy; Immunotherapy; PORTAL-VEIN LIGATION; RADIOFREQUENCY ABLATION; HEPATIC RESECTION; SORAFENIB; CHEMOTHERAPY; BEVACIZUMAB; COMBINATION; EFFICACY; PLUS;
D O I
10.4251/wjgo.v16.i10.4289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, the World Journal of Gastrointestinal Oncology published an article entitled "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature", in which the authors shared their successful experience with complete surgical resection after multidisciplinary conversion therapy. The study by Chu et al demonstrates the great challenges that the advanced hepatocellular carcinoma (HCC) poses to surgical oncology, reveals the complexity of conversion therapy for unresectable HCC, emphasizes the important role of a multidisciplinary management model in conversion therapy, and enriches our understanding of the dynamics of personalized treatment for different patients. At present, conversion therapy is a hot research topic in the treatment of unresectable HCC, which has brought new hope to many patients with moderately advanced HCC. However, there are still many urgent problems to be solved in conversion therapy. Here, we would like to further discuss the advances and challenges of conversion therapy for unresectable HCC with the authors and the general readers.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
    Kamal, Monica A.
    Mandour, Yasmine M.
    Abd El-Aziz, Mostafa K.
    Stein, Ulrike
    El Tayebi, Hend M.
    MOLECULES, 2022, 27 (17):
  • [42] Efficacy of Surgical Microwave Therapy in Patients with Unresectable Hepatocellular Carcinoma
    Itoh, Shinji
    Ikeda, Yasuharu
    Kawanaka, Hirofumi
    Okuyama, Toshirou
    Kawasaki, Katsumi
    Eguchi, Daihiko
    Korenaga, Daisuke
    Takenaka, Kenji
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (13) : 3650 - 3656
  • [43] Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
    Chadha, Awalpreet S.
    Gunther, Jillian R.
    Hsieh, Cheng-En
    Aliru, Maureen
    Mahadevan, Lakshmi S.
    Venkatesulu, Bhanu P.
    Crane, Christopher H.
    Das, Prajnan
    Herman, Joseph M.
    Koay, Eugene J.
    Taniguchi, Cullen
    Holliday, Emma B.
    Minsky, Bruce D.
    Suh, Yelin
    Park, Peter
    Sawakuchi, Gabriel
    Beddar, Sam
    Odisio, Bruno C.
    Gupta, Sanjay
    Loyer, Evelyne
    Kaur, Harmeet
    Raghav, Kanwal
    Javle, Milind M.
    Kaseb, Ahmed O.
    Krishnan, Sunil
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : 54 - 61
  • [44] Efficacy of Surgical Microwave Therapy in Patients with Unresectable Hepatocellular Carcinoma
    Shinji Itoh
    Yasuharu Ikeda
    Hirofumi Kawanaka
    Toshirou Okuyama
    Katsumi Kawasaki
    Daihiko Eguchi
    Daisuke Korenaga
    Kenji Takenaka
    Annals of Surgical Oncology, 2011, 18 : 3650 - 3656
  • [45] OUTCOMES OF PLANNED MULTIMODALITY THERAPY FOR UNRESECTABLE, UNTRANSPLANTABLE HEPATOCELLULAR CARCINOMA
    Kaneko, Shuichi
    Furuse, Junji
    Kudo, Masatoshi
    Ikeda, Kenji
    HEPATOLOGY, 2011, 54 : 1403A - 1404A
  • [46] Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
    Firouznia, Kavous
    Ghanaati, Hossein
    Alavian, Seyed Moayed
    Azadeh, Payam
    Toosi, Mohsen Nasiri
    Mirzaian, Arya Haj
    Najafi, Safa
    Shakiba, Madjid
    Jalali, Amir Hossein
    HEPATITIS MONTHLY, 2014, 14 (12) : e25792
  • [47] RADIATION-THERAPY IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA
    UNO, T
    ITAMI, J
    SHIINA, T
    TOITA, T
    MIKURIYA, S
    HATANO, K
    ARIMIZU, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 : S106 - S110
  • [48] 131I lipiodol therapy for unresectable hepatocellular carcinoma
    Rindani, RB
    Hugh, TJ
    Roche, J
    Roach, PJ
    Smith, RC
    ANZ JOURNAL OF SURGERY, 2002, 72 (03) : 210 - 214
  • [49] Advances in Immune Checkpoint Therapy in Hepatocellular Carcinoma
    Huang, Yamei
    Yu, Weiping
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (09)
  • [50] Reassessment of palliative surgery in conversion therapy of previously unresectable hepatocellular carcinoma: Two case reports and review of literature
    Zhu, Yang-Bo
    Qin, Jia-Yi
    Zhang, Ting-Ting
    Zhang, Wen-Jin
    Ling, Qi
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (10):